Cargando…

The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities

ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, John, Tsui, Hing Wo, Beier, Frank, Pritzker, Kenneth P.H., Inman, Robert D., Tsui, Florence W.L.
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577949/
https://www.ncbi.nlm.nih.gov/pubmed/19088867
http://dx.doi.org/10.2174/1874312900802010023
_version_ 1782160520581742592
author Wang, John
Tsui, Hing Wo
Beier, Frank
Pritzker, Kenneth P.H.
Inman, Robert D.
Tsui, Florence W.L.
author_facet Wang, John
Tsui, Hing Wo
Beier, Frank
Pritzker, Kenneth P.H.
Inman, Robert D.
Tsui, Florence W.L.
author_sort Wang, John
collection PubMed
description ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional consequences of one CPPDD-associated ANKH mutation (ΔE490) in chondrogenic ATDC5 cells. Stable ATDC5 transfectants bearing myc-tagged constructs of wild-type ANKH, mutant ANKH (ΔE490) and neo controls were generated. Upon ITS (insulin, transferrin and selenium) induction, expression of chondrocyte markers including alkaline phosphatase activity in the various transfectants was assessed. The ANKH ΔE490- transfectants had low alkaline phosphatase activities throughout ITS treatment due to lower TNAP protein expression and the presence of intracellular low-molecular-weight inhibitors. Our results suggest that the interplay of ANKH and TNAP activities is tightly regulated.
format Text
id pubmed-2577949
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Bentham Science Publishers Ltd.
record_format MEDLINE/PubMed
spelling pubmed-25779492008-12-16 The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities Wang, John Tsui, Hing Wo Beier, Frank Pritzker, Kenneth P.H. Inman, Robert D. Tsui, Florence W.L. Open Rheumatol J Article ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional consequences of one CPPDD-associated ANKH mutation (ΔE490) in chondrogenic ATDC5 cells. Stable ATDC5 transfectants bearing myc-tagged constructs of wild-type ANKH, mutant ANKH (ΔE490) and neo controls were generated. Upon ITS (insulin, transferrin and selenium) induction, expression of chondrocyte markers including alkaline phosphatase activity in the various transfectants was assessed. The ANKH ΔE490- transfectants had low alkaline phosphatase activities throughout ITS treatment due to lower TNAP protein expression and the presence of intracellular low-molecular-weight inhibitors. Our results suggest that the interplay of ANKH and TNAP activities is tightly regulated. Bentham Science Publishers Ltd. 2008-04-10 /pmc/articles/PMC2577949/ /pubmed/19088867 http://dx.doi.org/10.2174/1874312900802010023 Text en Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Wang, John
Tsui, Hing Wo
Beier, Frank
Pritzker, Kenneth P.H.
Inman, Robert D.
Tsui, Florence W.L.
The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title_full The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title_fullStr The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title_full_unstemmed The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title_short The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
title_sort ankh δe490mutation in calcium pyrophosphate dihydrate crystal deposition disease (cppdd) affects tissue non-specific alkaline phosphatase (tnap) activities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577949/
https://www.ncbi.nlm.nih.gov/pubmed/19088867
http://dx.doi.org/10.2174/1874312900802010023
work_keys_str_mv AT wangjohn theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT tsuihingwo theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT beierfrank theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT pritzkerkennethph theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT inmanrobertd theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT tsuiflorencewl theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT wangjohn ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT tsuihingwo ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT beierfrank ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT pritzkerkennethph ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT inmanrobertd ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities
AT tsuiflorencewl ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities